Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Rule

Showing results (131-140 of 276) with videos related to

Pageof 28
Sort By:
Critical Care Medicine|February 27, 2025
Cystatin C-Guided Dosing Nomogram Improves Target Attainment for Cefepime in the Critically IllErin F Barreto, Marc H Scheetz, Jack Chang, et al.
The New England Journal of Medicine|June 15, 2017
Single-Nephron Glomerular Filtration Rate in Healthy AdultsAleksandar Denic, Jerry Mathew, Lilach O Lerman, et al.
American Journal of Hypertension|May 31, 2006
A comparison of serum creatinine-based methods for identifying chronic kidney disease in hypertensive individuals and their siblingsAndrew D Rule, Steven J Jacobsen, Gary L Schwartz, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 19, 2013
Urine high and low molecular weight proteins one-year post-kidney transplant: relationship to histology and graft survivalH Amer, J C Lieske, A D Rule, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 30, 2017
Cystatin C-Guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement ProjectErin Frazee, Andrew D Rule, John C Lieske, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 30, 2012
Urolithiasis and the risk of ESRDZiad M El-Zoghby, John C Lieske, Robert N Foley, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|May 17, 2021
Renal Outcomes in Patients with Systolic Heart Failure Treated With Sacubitril-Valsartan or Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor BlockerNicholas Y Tan, Yihong Deng, Xiaoxi Yao, et al.
Antimicrobial Agents and Chemotherapy|October 26, 2023
Population pharmacokinetic model of cefepime for critically ill adults: a comparative assessment of eGFR equationsErin F Barreto, Jack Chang, Andrew D Rule, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 28, 2018
Risk of ESRD and Mortality in Kidney and Bladder Stone FormersTsering Dhondup, Wonngarm Kittanamongkolchai, Lisa E Vaughan, et al.
Mayo Clinic Proceedings|August 6, 2022
Dietary Risk Factors for Incident and Recurrent Symptomatic Kidney StonesApi Chewcharat, Charat Thongprayoon, Lisa E Vaughan, et al.
Pageof 28

Showing results (131-140 of 276) with videos related to

Sort By:
Pageof 28
Critical Care Medicine|February 27, 2025
Cystatin C-Guided Dosing Nomogram Improves Target Attainment for Cefepime in the Critically IllErin F Barreto, Marc H Scheetz, Jack Chang, et al.
The New England Journal of Medicine|June 15, 2017
Single-Nephron Glomerular Filtration Rate in Healthy AdultsAleksandar Denic, Jerry Mathew, Lilach O Lerman, et al.
American Journal of Hypertension|May 31, 2006
A comparison of serum creatinine-based methods for identifying chronic kidney disease in hypertensive individuals and their siblingsAndrew D Rule, Steven J Jacobsen, Gary L Schwartz, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 19, 2013
Urine high and low molecular weight proteins one-year post-kidney transplant: relationship to histology and graft survivalH Amer, J C Lieske, A D Rule, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 30, 2017
Cystatin C-Guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement ProjectErin Frazee, Andrew D Rule, John C Lieske, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 30, 2012
Urolithiasis and the risk of ESRDZiad M El-Zoghby, John C Lieske, Robert N Foley, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|May 17, 2021
Renal Outcomes in Patients with Systolic Heart Failure Treated With Sacubitril-Valsartan or Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor BlockerNicholas Y Tan, Yihong Deng, Xiaoxi Yao, et al.
Antimicrobial Agents and Chemotherapy|October 26, 2023
Population pharmacokinetic model of cefepime for critically ill adults: a comparative assessment of eGFR equationsErin F Barreto, Jack Chang, Andrew D Rule, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 28, 2018
Risk of ESRD and Mortality in Kidney and Bladder Stone FormersTsering Dhondup, Wonngarm Kittanamongkolchai, Lisa E Vaughan, et al.
Mayo Clinic Proceedings|August 6, 2022
Dietary Risk Factors for Incident and Recurrent Symptomatic Kidney StonesApi Chewcharat, Charat Thongprayoon, Lisa E Vaughan, et al.
Pageof 28